← All stocks

Inogen Inc

INGN Net selling
CIK 0001294133 #4118 in the set updated 20 Sep 2026
Bought (120 mo)
$254.16K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$191.64M
$142.46K on a plan · $103.02M straight out of an exercise
Sold at will
$88.48M
29 of 338 sales
Net
−$191.39M
−$88.23M against sales at will

By person

32 insiders · 362 transactions
1.2×

Kevin R.M. Smith holds only 1.2 times base salary in stock. $890.20K of shares against $711.08K in salary for 2025.

Salary from the company's own proxy. The shares are what Kevin R.M. Smith last reported holding, valued at $6.60, the price Common Stock was last bought or sold at on the open market here, on 1 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Novo Holdings A/S entity
10% owner
$77.69M (2)
−$77.69M
2,079,320
7.84%
$13.71M
−41.4%
Huggenberger Raymond
Director
$29.81M (74) scheduled
−$29.81M
17,583
0.0663%
$115.98K
+157.6%
Myers Byron
EVP, Marketing
$20.22M (31) scheduled
−$20.22M
37,327
0.1407%
$246.21K
+6.1%
Bauerlein Alison
EVP, Finance, & CFO
$19.51M (49) scheduled
−$19.51M
33,902
0.1277%
$223.61K
−10.9%
Taylor Brenton
EVP, Engineering
$17.26M (60) scheduled
−$17.26M
70,577
0.2659%
$465.52K
+58.8%
Wilkinson Scott
President and CEO
$15.18M (29) scheduled
−$15.18M
30,737
0.1158%
$202.74K
−21.9%
Scribner Matt
Former Officer
$5.09M (37) scheduled
−$5.09M
5,595
0.0211%
$36.90K
+139.8%
Lukatch Heath
Director
$86.02K (1)
$2.29M (23) scheduled
−$2.20M
12,775
0.0481%
$84.26K
+70,872%
Rider Heather D.
Director
$1.70M (11) scheduled
−$1.70M
118,282
0.4457%
$780.18K
+3,819%
McFarland Loren L
Director
$42.93K (1)
$1.39M (11) scheduled
−$1.35M
22,191
0.0836%
$146.37K
+606.0%
Anderson Ray Benjamin M
Director
$1.21M (6) scheduled
−$1.21M
19,807
0.0746%
$130.64K
+42.0%
Yi Boyer Jennifer M
EVP Entrprs Enblmnt, Ch HR Off
$142.46K (2) scheduled
−$142.46K
5,039
0.0190%
$33.24K
−62.7%
Somer Jason
EVP, Gen. Counsel & Secretary
$117.84K (2)
−$117.84K
4,690
0.0177%
$30.93K
Smith Kevin Raymond Merrill
CEO and President
$100.25K (1)
+$100.25K
134,962
0.5086%
$890.20K
Glezer Stanislav
EVP, R&D & Chief Med. Officer
$44.38K (1) scheduled
−$44.38K
32,049
0.1208%
$211.39K
Bourque Michael J.
EVP, CFO & Treasurer
$24.96K (1)
+$24.96K
94,596
0.3565%
$623.95K
Mora Elizabeth
Director
107,261
0.4042%
$707.48K
Boehnlein Glenn S
Director
104,966
0.3955%
$692.35K
Ladone Mary Kay
Director
104,966
0.3955%
$692.35K
King Kevin M
Director
104,966
0.3955%
$692.35K
GREER R SCOTT
Director
90,181
0.3398%
$594.82K
+51.8%
Sahney Mira Kirti
Director
67,805
0.2555%
$447.23K
Ramade Gregoire
Chief Commercial Officer
44,229
0.1667%
$291.73K
Jamali Vafa
Director
43,081
0.1623%
$284.16K
+187.2%
West Thomas A.
Director
40,677
0.1533%
$268.30K
Shabshab Nabil
CEO and President
36,991
0.1394%
$243.99K
Smith Kevin P.
EVP, Bus Dev, GC & Sec
32,972
0.1242%
$217.48K
Wright Mary E
VP, Chief Accounting Officer
20,629
0.0777%
$136.07K
+69.4%
Sanford Bart Ben
EVP, Operations
11,260
0.0424%
$74.27K
+415.6%
Miranda Kristen
Director
10,738
0.0405%
$70.83K
Parr George J
Chief Commercial Officer
8,175
0.0308%
$53.92K
Caltrider Kristin A.
EVP, CFO and Treasurer
5,129
0.0193%
$33.83K
Insider
Date
Role
Action
Shares
Price
Amount
Smith Kevin Raymond Merrill
3 Mar 2025
CEO and President
Buy
11,709
$8.56
$100.25K
Bourque Michael J.
3 Mar 2025
EVP, CFO & Treasurer
Buy
3,000
$8.32
$24.96K
McFarland Loren L
4 Sep 2019
Director
Buy
1,000
$42.93
$42.93K
Lukatch Heath
15 Aug 2019
Director
Buy
2,000
$43.01
$86.02K
Showing 250 of 362 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 378
Amendments (4/A) skipped 9
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 307
Sales at will 29
Transactions with no price 0
Shares from compensation/vesting 3,030,064
Sales filed before the plan box existed 28
History held since 12 Sep 2016